- Antimicrobial Agents
- Antiplaque Agents
- Nanoparticles
- Photodynamic Therapy
- Cold Atmospheric Plasma
- Herbal/Natural Products
- Others
Oral Biofilm Therapeutics Market size was valued at USD 612.4 million in 2023 and is anticipated to grow at a CAGR of 8.2% from 2024-2030. Oral biofilms are complex and dynamic communities of microorganisms that form on various surfaces within the human oral cavity, particularly on teeth and gums. Dental plaque is one of the most commonly forming biofilms in the oral cavity and appears as a slimy layer on the surface of the teeth.
The prevalence of oral diseases plays a pivotal role in driving the growth of the oral biofilm therapy market revenues. Oral diseases, such as dental caries (cavities) and periodontal diseases (gum diseases), implant-related infections, and oropharyngeal candidiasis are closely linked to the formation and persistence of oral biofilms on teeth and gums. As these conditions affect a significant portion of the global population, there is a substantial demand for effective therapeutic solutions to address them. Oral biofilm therapy offers targeted treatments designed to combat the microbial communities within biofilms, preventing and managing oral diseases. Moreover, the growth of the oral biofilm therapy market is significantly driven by the combined forces of growing awareness of oral health and advancements in dental research. Increasing awareness among the general population about the importance of oral hygiene, regular dental check-ups, and the role of oral biofilms in causing dental diseases has spurred demand for effective treatments. Concurrently, ongoing research in dentistry and microbiology has provided deeper insights into the complex nature of oral biofilms and their implications for oral health. These advancements have paved the way for the development of targeted and innovative therapeutic approaches to address oral biofilm-related conditions.
However, developing and gaining regulatory approval for new therapeutic agents can be a lengthy and costly process. Hence stringent regulatory requirements and costly treatment options can limit the growth of the oral biofilm therapy market. Meanwhile, rising healthcare investments can create significant opportunities for market development. Moreover, key market players are announcing innovative launches, strategic collaborations, and several acquisitions to further contribute to the market growth.
Study Period
2024-2030Base Year
2023CAGR
8.2%Largest Market
North AmericaFastest Growing Market
Asia Pacific
The aging population plays a significant role in driving the oral biofilm therapy market further. As individuals age, they become more susceptible to a range of oral health issues, including dental caries, periodontal diseases, and other conditions associated with oral biofilms. This demographic's increased vulnerability to oral diseases underscores the importance of effective oral biofilm therapy to maintain their oral health and overall well-being. Moreover, the globalization of dental care is a significant driver behind the growth of the oral biofilm therapy market. Dental care practices, research, and innovations are increasingly being shared and adopted on a global scale. As dental care becomes more accessible and standardized across different regions, the awareness of oral health issues and the importance of effective treatments for oral biofilm-related conditions expands.
By Treatment Options
By End Users
By Geography
The oral biofilm therapy market was valued at USD 612.4 Million in 2023
The oral biofilm therapeutics market key players are: EMS Philips Dentsply Sirona Periogen GC Corporation Waterpik OraVital Inc CURADEN AG Oral-Breeze Sunstar Americas, Inc
The oral biofilm therapeutics market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
1. Executive Summary |
2. Global Oral Biofilm Therapeutics Market Introduction |
2.1.Global Oral Biofilm Therapeutics Market - Taxonomy |
2.2.Global Oral Biofilm Therapeutics Market - Definitions |
2.2.1.Treatment Options |
2.2.2.End Users |
2.2.3.Region |
3. Global Oral Biofilm Therapeutics Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID-19 on Market |
4. Global Oral Biofilm Therapeutics Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Oral Biofilm Therapeutics Market By Treatment Options, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Antimicrobial Agents |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Antiplaque Agents |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Nanoparticles |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Photodynamic Therapy |
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Cold Atmospheric Plasma |
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
5.6. Herbal/Natural Products |
5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.6.3. Market Opportunity Analysis |
5.7. Others |
5.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.7.3. Market Opportunity Analysis |
6. Global Oral Biofilm Therapeutics Market By End Users, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Hospitals and Clinics |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Academic Institutes and Research Centers |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Others |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7. Global Oral Biofilm Therapeutics Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. North America |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Europe |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Asia Pacific (APAC) |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Middle East and Africa (MEA) |
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Latin America |
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
8.North America Oral Biofilm Therapeutics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. Treatment Options Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.1.1.Antimicrobial Agents |
8.1.2.Antiplaque Agents |
8.1.3.Nanoparticles |
8.1.4.Photodynamic Therapy |
8.1.5.Cold Atmospheric Plasma |
8.1.6.Herbal/Natural Products |
8.1.7.Others |
8.2. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.2.1.Hospitals and Clinics |
8.2.2.Academic Institutes and Research Centers |
8.2.3.Others |
8.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.3.1.United States of America (USA) |
8.3.2.Canada |
9.Europe Oral Biofilm Therapeutics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. Treatment Options Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Antimicrobial Agents |
9.1.2.Antiplaque Agents |
9.1.3.Nanoparticles |
9.1.4.Photodynamic Therapy |
9.1.5.Cold Atmospheric Plasma |
9.1.6.Herbal/Natural Products |
9.1.7.Others |
9.2. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Hospitals and Clinics |
9.2.2.Academic Institutes and Research Centers |
9.2.3.Others |
9.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Germany |
9.3.2.France |
9.3.3.Italy |
9.3.4.United Kingdom (UK) |
9.3.5.Spain |
9.3.6.Rest of EU |
10.Asia Pacific (APAC) Oral Biofilm Therapeutics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Treatment Options Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Antimicrobial Agents |
10.1.2.Antiplaque Agents |
10.1.3.Nanoparticles |
10.1.4.Photodynamic Therapy |
10.1.5.Cold Atmospheric Plasma |
10.1.6.Herbal/Natural Products |
10.1.7.Others |
10.2. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Hospitals and Clinics |
10.2.2.Academic Institutes and Research Centers |
10.2.3.Others |
10.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.China |
10.3.2.India |
10.3.3.Australia and New Zealand (ANZ) |
10.3.4.Japan |
10.3.5.Rest of APAC |
11.Middle East and Africa (MEA) Oral Biofilm Therapeutics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Treatment Options Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Antimicrobial Agents |
11.1.2.Antiplaque Agents |
11.1.3.Nanoparticles |
11.1.4.Photodynamic Therapy |
11.1.5.Cold Atmospheric Plasma |
11.1.6.Herbal/Natural Products |
11.1.7.Others |
11.2. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Hospitals and Clinics |
11.2.2.Academic Institutes and Research Centers |
11.2.3.Others |
11.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.GCC Countries |
11.3.2.South Africa |
11.3.3.Rest of MEA |
12.Latin America Oral Biofilm Therapeutics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Treatment Options Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Antimicrobial Agents |
12.1.2.Antiplaque Agents |
12.1.3.Nanoparticles |
12.1.4.Photodynamic Therapy |
12.1.5.Cold Atmospheric Plasma |
12.1.6.Herbal/Natural Products |
12.1.7.Others |
12.2. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Hospitals and Clinics |
12.2.2.Academic Institutes and Research Centers |
12.2.3.Others |
12.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Brazil |
12.3.2.Mexico |
12.3.3.Rest of LA |
13. Competition Landscape |
13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
13.2.1.EMS |
13.2.2.Philips |
13.2.3.Dentsply Sirona |
13.2.4.Periogen |
13.2.5.GC Corporation |
13.2.6.Waterpik |
13.2.7.OraVital Inc |
13.2.8.CURADEN AG |
13.2.9.Oral-Breeze |
13.2.10.Sunstar Americas, Inc |
14. Research Methodology |
15. Appendix and Abbreviations |